
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $391M | $439.7M | $473.2M | $544.9M | $695.2M | |
Revenue Growth (YoY) | 15.49% | 12.47% | 7.63% | 15.14% | 27.59% | |
Cost of Revenues | $336.1M | $391.1M | $414.7M | $477.9M | $601.5M | |
Gross Profit | $54.9M | $48.6M | $58.6M | $67M | $93.8M | |
Gross Profit Margin | 14.04% | 11.05% | 12.38% | 12.3% | 13.49% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $31.3M | $36.3M | $34M | $36.7M | $50.2M | |
Other Inc / (Exp) | $225K | -$2.9M | -$7M | $269K | $889K | |
Operating Expenses | $36M | $41M | $38.9M | $41.8M | $56.3M | |
Operating Income | $18.9M | $7.6M | $19.7M | $25.2M | $37.4M | |
Net Interest Expenses | $1.2M | $1.9M | $3.8M | $5.9M | $7M | |
EBT. Incl. Unusual Items | $17.9M | $2.7M | $8.9M | $19.6M | $31.4M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $2.4M | $582K | $1.6M | $5.7M | $7M | |
Net Income to Company | $15.6M | $2.1M | $7.2M | $13.9M | $24.3M | |
Minority Interest in Earnings | $191K | $548K | -$600K | -$531K | -$1.8M | |
Net Income to Common Excl Extra Items | $15.7M | $2.7M | $6.6M | $13.4M | $22.6M | |
Basic EPS (Cont. Ops) | $0.56 | $0.09 | $0.23 | $0.45 | $0.72 | |
Diluted EPS (Cont. Ops) | $0.52 | $0.09 | $0.22 | $0.44 | $0.70 | |
Weighted Average Basic Share | $28M | $28.4M | $29.1M | $29.9M | $31.2M | |
Weighted Average Diluted Share | $30.2M | $30.6M | $30.2M | $30.2M | $32M | |
EBITDA | $23.8M | $9.5M | $17.6M | $30.6M | $44.4M | |
EBIT | $19.1M | $4.7M | $12.7M | $25.5M | $38.3M | |
Revenue (Reported) | $391M | $439.7M | $473.2M | $544.9M | $695.2M | |
Operating Income (Reported) | $18.9M | $7.6M | $19.7M | $25.2M | $37.4M | |
Operating Income (Adjusted) | $19.1M | $4.7M | $12.7M | $25.5M | $38.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $105.7M | $113.9M | $126.5M | $156.9M | $209.8M | |
Revenue Growth (YoY) | 15.04% | 7.81% | 11.02% | 24.08% | 33.73% | |
Cost of Revenues | $93.6M | $100.3M | $112.2M | $136.4M | $180.5M | |
Gross Profit | $12.1M | $13.6M | $14.3M | $20.5M | $29.4M | |
Gross Profit Margin | 11.43% | 11.94% | 11.28% | 13.09% | 14% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $9.3M | $10M | $8.7M | $11.4M | $14.8M | |
Other Inc / (Exp) | -- | -$89K | $30K | $840K | -$69K | |
Operating Expenses | $10.5M | $11.2M | $10M | $12.8M | $16.7M | |
Operating Income | $1.6M | $2.4M | $4.3M | $7.8M | $12.7M | |
Net Interest Expenses | $360K | $629K | $1.4M | $1.8M | $1.2M | |
EBT. Incl. Unusual Items | $1.3M | $1.7M | $2.9M | $6.8M | $11.4M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $340K | $542K | $907K | $1.8M | $2.9M | |
Net Income to Company | $913K | $1.2M | $2M | $5.1M | $8.5M | |
Minority Interest in Earnings | $37K | -$144K | -$147K | -$152K | -$747K | |
Net Income to Common Excl Extra Items | $950K | $1M | $1.9M | $4.9M | $7.8M | |
Basic EPS (Cont. Ops) | $0.03 | $0.04 | $0.06 | $0.16 | $0.23 | |
Diluted EPS (Cont. Ops) | $0.03 | $0.03 | $0.06 | $0.16 | $0.22 | |
Weighted Average Basic Share | $28.3M | $28.6M | $29.8M | $30M | $34.5M | |
Weighted Average Diluted Share | $30.9M | $30.1M | $30.1M | $30.4M | $35.2M | |
EBITDA | $2.8M | $3.5M | $5.6M | $9.9M | $14.5M | |
EBIT | $1.6M | $2.3M | $4.3M | $8.6M | $12.6M | |
Revenue (Reported) | $105.7M | $113.9M | $126.5M | $156.9M | $209.8M | |
Operating Income (Reported) | $1.6M | $2.4M | $4.3M | $7.8M | $12.7M | |
Operating Income (Adjusted) | $1.6M | $2.3M | $4.3M | $8.6M | $12.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $404.8M | $447.9M | $485.8M | $575.3M | $748.2M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $349.8M | $397.8M | $426.5M | $502M | $645.6M | |
Gross Profit | $55M | $50.1M | $59.3M | $73.3M | $102.6M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $33.9M | $37M | $32.7M | $39.4M | $53.6M | |
Other Inc / (Exp) | $225K | -$3M | -$6.9M | $1.1M | -$20K | |
Operating Expenses | $38.8M | $41.8M | $37.7M | $44.6M | $60.3M | |
Operating Income | $16.3M | $8.4M | $21.6M | $28.7M | $42.3M | |
Net Interest Expenses | $1.2M | $2.2M | $4.6M | $6.3M | $6.4M | |
EBT. Incl. Unusual Items | $15.3M | $3.2M | $10.1M | $23.5M | $35.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $1.8M | $784K | $2M | $6.5M | $8.1M | |
Net Income to Company | $13.5M | $2.4M | $8.1M | $17M | $27.8M | |
Minority Interest in Earnings | $228K | $367K | -$603K | -$536K | -$2.4M | |
Net Income to Common Excl Extra Items | $13.7M | $2.8M | $7.5M | $16.4M | $25.4M | |
Basic EPS (Cont. Ops) | $0.49 | $0.09 | $0.25 | $0.55 | $0.79 | |
Diluted EPS (Cont. Ops) | $0.46 | $0.08 | $0.25 | $0.54 | $0.76 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $21.3M | $10.1M | $19.7M | $35M | $49M | |
EBIT | $16.5M | $5.4M | $14.7M | $29.8M | $42.3M | |
Revenue (Reported) | $404.8M | $447.9M | $485.8M | $575.3M | $748.2M | |
Operating Income (Reported) | $16.3M | $8.4M | $21.6M | $28.7M | $42.3M | |
Operating Income (Adjusted) | $16.5M | $5.4M | $14.7M | $29.8M | $42.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $105.7M | $113.9M | $126.5M | $156.9M | $209.8M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $93.6M | $100.3M | $112.2M | $136.4M | $180.5M | |
Gross Profit | $12.1M | $13.6M | $14.3M | $20.5M | $29.4M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $9.3M | $10M | $8.7M | $11.4M | $14.8M | |
Other Inc / (Exp) | -- | -$89K | $30K | $840K | -$69K | |
Operating Expenses | $10.5M | $11.2M | $10M | $12.8M | $16.7M | |
Operating Income | $1.6M | $2.4M | $4.3M | $7.8M | $12.7M | |
Net Interest Expenses | $360K | $629K | $1.4M | $1.8M | $1.2M | |
EBT. Incl. Unusual Items | $1.3M | $1.7M | $2.9M | $6.8M | $11.4M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $340K | $542K | $907K | $1.8M | $2.9M | |
Net Income to Company | $913K | $1.2M | $2M | $5.1M | $8.5M | |
Minority Interest in Earnings | $37K | -$144K | -$147K | -$152K | -$747K | |
Net Income to Common Excl Extra Items | $950K | $1M | $1.9M | $4.9M | $7.8M | |
Basic EPS (Cont. Ops) | $0.03 | $0.04 | $0.06 | $0.16 | $0.23 | |
Diluted EPS (Cont. Ops) | $0.03 | $0.03 | $0.06 | $0.16 | $0.22 | |
Weighted Average Basic Share | $28.3M | $28.6M | $29.8M | $30M | $34.5M | |
Weighted Average Diluted Share | $30.9M | $30.1M | $30.1M | $30.4M | $35.2M | |
EBITDA | $2.8M | $3.5M | $5.6M | $9.9M | $14.5M | |
EBIT | $1.6M | $2.3M | $4.3M | $8.6M | $12.6M | |
Revenue (Reported) | $105.7M | $113.9M | $126.5M | $156.9M | $209.8M | |
Operating Income (Reported) | $1.6M | $2.4M | $4.3M | $7.8M | $12.7M | |
Operating Income (Adjusted) | $1.6M | $2.3M | $4.3M | $8.6M | $12.6M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $43K | $5.2M | $2.1M | $6.1M | $24.2M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $47.2M | $53.9M | $53.4M | $61.1M | $81.3M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | $12.3M | -- | -- | -- | -- | |
Other Current Assets | -- | $16.7M | $18.3M | $12.9M | $17.3M | |
Total Current Assets | $59.6M | $75.8M | $73.8M | $80.1M | $122.9M | |
Property Plant And Equipment | $326.5M | $317.8M | $287.5M | $291.5M | $313.9M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $66.4M | $74.3M | $79.5M | $91M | $129.1M | |
Other Intangibles | $47.5M | $53.7M | $58.6M | $67.7M | $96.2M | |
Other Long-Term Assets | $4.8M | $4.8M | $10.5M | $9.3M | $17.5M | |
Total Assets | $507M | $530.3M | $512.1M | $539.7M | $679.5M | |
Accounts Payable | $9.8M | $10.6M | $13.6M | $10.8M | $18.7M | |
Accrued Expenses | $37.5M | $33.1M | $33.6M | $38.3M | $56.7M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $14.1M | $16.1M | $16.6M | $17.1M | $19.7M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $89M | $71.6M | $70.2M | $71.5M | $101.7M | |
Long-Term Debt | $8.3M | $51.4M | $62.9M | $63.9M | -- | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $405.8M | $416.1M | $386.5M | $394.2M | $367.6M | |
Common Stock | $28K | $28K | $29K | $29K | $35K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | $96.6M | $110.2M | $121M | $140.3M | $293.3M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $4.6M | $4M | $4.6M | $5.2M | $18.7M | |
Total Equity | $101.2M | $114.2M | $125.7M | $145.5M | $312M | |
Total Liabilities and Equity | $507M | $530.3M | $512.1M | $539.7M | $679.5M | |
Cash and Short Terms | $43K | $5.2M | $2.1M | $6.1M | $24.2M | |
Total Debt | $8.3M | $51.4M | $62.9M | $63.9M | -- |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $5.6M | $3.6M | $3M | $2.7M | $5.2M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $50.8M | $56.9M | $50.7M | $71.4M | $95M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | $15.3M | $21M | -- | -- | -- | |
Other Current Assets | -- | -- | $13.1M | $13M | $23.7M | |
Total Current Assets | $71.7M | $81.5M | $66.8M | $87.1M | $123.9M | |
Property Plant And Equipment | $323.3M | $290.4M | $291.1M | $299.4M | $321.7M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $68.2M | $74.3M | $79.5M | $107.2M | $154.9M | |
Other Intangibles | $49.4M | $53.7M | $58.8M | $74.9M | $118.9M | |
Other Long-Term Assets | $4.8M | $5.4M | $10.7M | $9.7M | $24.2M | |
Total Assets | $519.3M | $507.4M | $508.2M | $578.2M | $743.6M | |
Accounts Payable | $8.6M | $10.9M | $12.2M | $13.1M | $18.8M | |
Accrued Expenses | $32.4M | $33.9M | $30.9M | $39.6M | $42.1M | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | $14.6M | $16.4M | $16.9M | $17.4M | $20.6M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $88.4M | $68.6M | $65.6M | $75.2M | $88M | |
Long-Term Debt | $25M | $56.5M | $57M | $83.3M | $52.5M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $414.6M | $389.5M | $378.9M | $414M | $420.6M | |
Common Stock | $28K | $29K | $29K | $30K | $35K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $4.6M | $4.2M | $4.8M | $17.1M | $19.4M | |
Total Equity | $104.7M | $117.9M | $129.2M | $164.2M | $323M | |
Total Liabilities and Equity | $519.3M | $507.4M | $508.2M | $578.2M | $743.6M | |
Cash and Short Terms | $5.6M | $3.6M | $3M | $2.7M | $5.2M | |
Total Debt | $25M | $56.5M | $57M | $83.3M | $52.5M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $15.6M | $2.1M | $7.2M | $13.9M | $24.3M | |
Depreciation & Amoritzation | $4.7M | $4.8M | $4.9M | $5.1M | $6.1M | |
Stock-Based Compensation | $8.3M | $10M | $3.1M | $5.4M | $7.8M | |
Change in Accounts Receivable | -$15.7M | -$7.3M | -$361K | -$7.4M | -$21.1M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $50.2M | -$18.2M | $9M | $33.1M | $39.3M | |
Capital Expenditures | $7.3M | $6.3M | $14.2M | $8.1M | $9M | |
Cash Acquisitions | -$33.2M | -$13.6M | -$10.1M | -$21.4M | -$48.4M | |
Cash From Investing | -$41.6M | -$20.1M | -$24.2M | -$30.2M | -$70.7M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $52.7M | $125.5M | $129.5M | $182M | $309.5M | |
Long-Term Debt Repaid | -$63.2M | -$81.5M | -$118.5M | -$181.5M | -$374.5M | |
Repurchase of Common Stock | -$65K | -- | -- | -- | -- | |
Other Financing Activities | $477K | -$1.4M | -- | $33K | -$4.4M | |
Cash From Financing | -$8.9M | $43.5M | $12.1M | $1.1M | $49.6M | |
Beginning Cash (CF) | $402K | $43K | $5.2M | $2.1M | $6.1M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$359K | $5.1M | -$3.1M | $4M | $18.2M | |
Ending Cash (CF) | $43K | $5.2M | $2.1M | $6.1M | $24.2M | |
Levered Free Cash Flow | $43M | -$24.5M | -$5.1M | $25M | $30.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $913K | $1.2M | $2M | $5.1M | $8.5M | |
Depreciation & Amoritzation | $1.2M | $1.1M | $1.3M | $1.3M | $1.9M | |
Stock-Based Compensation | $2.4M | $2.4M | $1.4M | $1.4M | $2.1M | |
Change in Accounts Receivable | -$3.8M | -$3.2M | $3.2M | -$10.5M | -$13.9M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$7.3M | -$4.1M | $9M | $545K | -$21.2M | |
Capital Expenditures | $754K | $2.4M | $2.3M | $3.1M | $2M | |
Cash Acquisitions | -$3.1M | -- | -- | -$11.7M | -$47.6M | |
Cash From Investing | -$4M | -$2.6M | -$2.3M | -$23.6M | -$50.3M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $39M | $11M | $40.5M | $69M | $96.5M | |
Long-Term Debt Repaid | -$21M | -$6M | -$46.5M | -$49.8M | -$44M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$1.4M | -- | -- | $11K | -$387K | |
Cash From Financing | $16.8M | $5.1M | -$5.8M | $19.8M | $52.5M | |
Beginning Cash (CF) | $43K | $5.2M | $2.1M | $6.1M | $24.2M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $5.6M | -$1.6M | $873K | -$3.3M | -$19M | |
Ending Cash (CF) | $5.6M | $3.6M | $3M | $2.7M | $5.2M | |
Levered Free Cash Flow | -$8M | -$6.5M | $6.7M | -$2.6M | -$23.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $13.5M | $2.4M | $8.1M | $17M | $27.8M | |
Depreciation & Amoritzation | $4.8M | $4.8M | $5M | $5.2M | $6.7M | |
Stock-Based Compensation | $8.8M | $10.1M | $2M | $5.4M | $8.5M | |
Change in Accounts Receivable | -$15.8M | -$6.7M | $6M | -$21M | -$24.5M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $40.8M | -$15M | $22.1M | $24.6M | $17.5M | |
Capital Expenditures | $5.1M | $7.9M | $14.1M | $8.9M | $7.8M | |
Cash Acquisitions | -$33.3M | -$10.5M | -$10.1M | -$33.1M | -$84.4M | |
Cash From Investing | -$38.8M | -$18.7M | -$24M | -$51.5M | -$97.3M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $68.2M | $97.5M | $159M | $210.5M | $337M | |
Long-Term Debt Repaid | -$69.7M | -$66.5M | -$159M | -$184.8M | -$368.8M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$891K | -- | -- | -- | -$4.8M | |
Cash From Financing | -$1.2M | $31.8M | $1.2M | $26.7M | $82.3M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $773K | -$2M | -$675K | -$230K | $2.5M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $35.8M | -$23M | $8M | $15.7M | $9.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $913K | $1.2M | $2M | $5.1M | $8.5M | |
Depreciation & Amoritzation | $1.2M | $1.1M | $1.3M | $1.3M | $1.9M | |
Stock-Based Compensation | $2.4M | $2.4M | $1.4M | $1.4M | $2.1M | |
Change in Accounts Receivable | -$3.8M | -$3.2M | $3.2M | -$10.5M | -$13.9M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | -$7.3M | -$4.1M | $9M | $545K | -$21.2M | |
Capital Expenditures | $754K | $2.4M | $2.3M | $3.1M | $2M | |
Cash Acquisitions | -$3.1M | -- | -- | -$11.7M | -$47.6M | |
Cash From Investing | -$4M | -$2.6M | -$2.3M | -$23.6M | -$50.3M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $39M | $11M | $40.5M | $69M | $96.5M | |
Long-Term Debt Repaid | -$21M | -$6M | -$46.5M | -$49.8M | -$44M | |
Repurchase of Common Stock | -- | -- | -- | -- | -- | |
Other Financing Activities | -$1.4M | -- | -- | $11K | -$387K | |
Cash From Financing | $16.8M | $5.1M | -$5.8M | $19.8M | $52.5M | |
Beginning Cash (CF) | $43K | $5.2M | $2.1M | $6.1M | $24.2M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $5.6M | -$1.6M | $873K | -$3.3M | -$19M | |
Ending Cash (CF) | $5.6M | $3.6M | $3M | $2.7M | $5.2M | |
Levered Free Cash Flow | -$8M | -$6.5M | $6.7M | -$2.6M | -$23.2M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.